CoChat

The Effect of Complement Factor H Y402H Polymorphism on the Outcome of Photodynamic Therapy in Age-related Macular Degeneration

Seitsonen, S.P., Järvelä, I.E., Meri, S., Tommila, P.V., Ranta, P.H., Immonen, I.J. · 2007 · European Journal of Ophthalmology

The DOI matches its Crossref record; 37 of the 38 references it cites were found in a registry or an index.

Abstract

Purpose: Photodynamic therapy (PDT) has been widely used in the treatment of age-related macular degeneration (AMD). The complement cascade has an important role in the tissue reactions occurring after PDT. The Y402H polymorphism of the complement factor H (CFH) gene has been identified as a risk factor for AMD. Since CFH is central in the regulation of the complement system the authors wanted to analyze whether the CFH Y402H polymorphism modifies the PDT outcome in AMD. Methods: A total of 88 patients having been treated with PDT and without further scheduled PDT sessions were analyzed. Depending on the situation at their final PDT session the patients were classified retrospectively as PDT-responders or PDT-nonresponders. All patients were genotyped for the CFH Y402H polymorphism. Results: The proportion of PDT-responders was 18/26 (69.2%) in patients homozygous for the CFH Y402H risk allele, 34/50 (68.0%) in heterozygous, and 7/12 (58.3%) in patients with the normal genotype (p=0.520). The median number of PDT treatments of the PDT-responders was three for all the genotypes. Conclusions: The dysfunction of the CFH related to the risk of AMD and caused by the Y402H polymorphism does not modify the outcome of PDT. Genotyping for CFH Y402H cannot be used to select patients for this treatment.

Overview

Integrity signals

Registry

Crossref · 10.1177/112067210701700612

Cites

37 of 37 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 37 references

Research works printed but not linked: 6

  1. Husain D., 1999, Invest Ophthalmol Vis Sci, 40, 2322
  2. Schmidt-Erfurth U., 2002, Invest Ophthalmol Vis Sci, 43, 830
  3. Souied E.H., 2005, Mol Vis, 11, 1135
  4. Seitsonen S., 2006, Mol Vis, 12, 796
  5. Bressler NM; Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group, 2001, Arch Ophthalmol, 119, 198
  6. Goverdhan S.V., 2007, Eye

Cited by

See all 48

Metadata

Authors
Seitsonen, S. P., Järvelä, I. E., Meri, S., Tommila, P. V., Ranta, P. H., & Immonen, I. J.
Affiliations
  • Helsinki University Hospital (FI)
  • University of Helsinki (FI)
Venue
European Journal of Ophthalmology
Published
2007-11
Volume
17
Issue
6
Pages
943-949
ISSN
  • 1120-6721 (ISSN-L)
  • 1724-6016
OpenAlex
W2143894968
Cited by
48
References
38
Citations by year
2024: 1 · 2023: 1 · 2018: 1 · 2017: 1 · 2014: 4 · 2013: 8 · 2012: 10
FWCI
4.49
Type
journal article
Language
en
Open access
closed
Licence
journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
Locations
  • European Journal of Ophthalmology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Ophthalmology › Retinal Diseases and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Photodynamic Therapy Research Studies
  • Life Sciences › Immunology and Microbiology › Immunology › Complement system in diseases
Keywords
complement factor H, CFH Y402H polymorphism, age-related macular degeneration, photodynamic therapy, treatment response, genetic susceptibility, complement system
MeSH terms
Aged, Female, Genotype, Humans, Macular Degeneration, Male, Photochemotherapy, Visual Acuity, Polymerase Chain Reaction, Treatment Outcome, Complement Factor H, Polymorphism, Single Nucleotide

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Effect of Complement Factor H Y402H Polymorphism on the Outcome of Photodynamic Therapy in Age-related Macular Degeneration. https://app.cochat.ai/papers/10.1177/112067210701700612
The paper
Seitsonen, S. P., Järvelä, I. E., Meri, S., Tommila, P. V., Ranta, P. H., & Immonen, I. J. (2007). The Effect of Complement Factor H Y402H Polymorphism on the Outcome of Photodynamic Therapy in Age-related Macular Degeneration. European Journal of Ophthalmology. https://doi.org/10.1177/112067210701700612

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.